Delphine Allorge

Université de Lille

Papers

1

Total Citations

1

H-Index

1

About

Delphine Allorge is a leading researcher in pharmaceutical safety and contamination control, with a primary focus on the safe handling of hazardous drugs, particularly cytotoxic agents used in cancer therapy. Her work addresses critical challenges in hospital pharmacy practice, notably the assessment of chemical contamination risks associated with robotic compounding systems. In her landmark pilot study on the RIVA™ compounding robot, Allorge provided the first detailed evaluation of cytotoxic contamination both inside and outside this automated system, offering essential data for improving occupational safety protocols. Although her most-cited paper currently holds 1 citation, its recent publication in 2024 signals emerging impact in a niche but vital field. Allorge’s contributions are pivotal for hospitals adopting robotic technologies, as her findings help define best practices for minimizing exposure to dangerous drugs. Her research bridges engineering, pharmacy, and public health, making her a key voice in the movement toward safer, automated pharmaceutical preparation.

Research Focus

Key Achievements

1
H-Index
1
Papers
1
Total Citations
1
Avg Citations/Paper
🏆 Most Cited Paper
Assessment of chemical contamination by cancer drugs during use of the RIVA <sup>TM</sup> compounding robot: A pilot study
1 citations · 2024
📈 Most Prolific Year: 2024 (1 Papers)
🤝 Key Collaborators: 7
🏛 Institutions: Université de Lille

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago